Brief: Veracyte Announces Expanded Availability Of Decipher Prostate Test To Patients With Metastatic Prostate Cancer
25/04/2025 12:24
April 25 (Reuters) - Veracyte Inc VCYT.O: VERACYTE ANNOUNCES EXPANDED AVAILABILITY OF DECIPHER PROSTATE TEST TO PATIENTS WITH METASTATIC PROSTATE CANCER VERACYTE INC - DECIPHER PROSTATE METASTATIC TEST ORDERS BEGIN JUNE 2025 Source text: ID:nBw83nJ0ja Further company coverage: VCYT.O
Recent news on Veracyte
See all newsU.S. STOCKS ON THE MOVE-Vor Biopharma, Fair Isaac Corp, Plug Power
U.S. STOCKS ON THE MOVE-Snowflake, Cboe, Oracle
US STOCKS ON THE MOVE-Veracyte, Staar Surgical, Corning
Veracyte gains on data supporting use of prostate cancer test to guide treatment decisions
Corrected: U.S. RESEARCH ROUNDUP-Abbvie, Amazon, Illumina